Increased interleukin-6/C-reactive protein levels are associated with the upregulation of the adenosine pathway and serve as potential markers of therapeutic resistance to immune checkpoint inhibitor-based therapies in non-small cell lung cancer - Naqash,AR; Mccallen,JD; Mi,E; Iivanainen,S; Marie,MA; Gramenitskaya,D; Clark,J; Koivunen,JP; Macherla,S; Jonnalagadda,S; Polsani,S; Jiwani,RA; et al. (JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023)